BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 648939)

  • 1. Serum carbenoxolone in patients with gastric and duodenal ulcer: Absorption, efficacy and side-effects.
    Baron JH; Gribble JN; Rhodes C; Wright PA
    Gut; 1978 Apr; 19(4):330-5. PubMed ID: 648939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carbenoxolone: ulcer-healing and metabolic effects.
    Wright PA; Reed PI; Davies WA; St John DJ; Young GP; House FR; Gribble RJ; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():41-8. PubMed ID: 6937940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of Duogastrone in duodenal ulcer.
    Davies WA; Reed PI
    Gut; 1977 Jan; 18(1):78-83. PubMed ID: 320112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.
    Pinder RM; Brogden RN; Sawyer PR; Speight TM; Spencer R; Avery GS
    Drugs; 1976; 11(4):245-307. PubMed ID: 780088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of carbenoxolone sodium on human gastric acid secretion.
    Baron JH
    Gut; 1977 Sep; 18(9):721-2. PubMed ID: 604192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbenoxolone sodium capsules in the treatment of duodenal ulcer. An endoscopic controlled trial.
    Gut; 1977 Sep; 18(9):717-20. PubMed ID: 342359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Duogastrome (carbenoxolone sodium) for the treatment of duodenal ulcer: a multicentre study.
    Archambault A; Farley A; Gosselin D; Martin F; Birkett JP
    Can Med Assoc J; 1977 Nov; 117(10):1155-9. PubMed ID: 603844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
    Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
    Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of peptic ulcer with Biogastrone (carbenoxolone)].
    Brailski Kh; Dimitrov B
    Vutr Boles; 1979; 18(5):37-44. PubMed ID: 516651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of duodenal ulcer with carbenoxolone sodium: a double-masked endoscopic trial.
    Young GP; St John DJ; Coventry DA
    Med J Aust; 1979 Jan; 1(1):2-5. PubMed ID: 368533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
    Reed PI; Lewis SI; Vincent-Brown A; Holdstock DJ; Gribble RJ; Murgatroyd RE; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():51-7. PubMed ID: 7010528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carbenoxolone sodium in the treatment of duodenal ulcer.
    Nagy GS
    Gastroenterology; 1978 Jan; 74(1):7-10. PubMed ID: 336453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of peptic ulcer in the stomach and duodenum using carbenoxolone (Biogastrone and Biogastrone-Duodenal)].
    Ronský R; Fric P; Huslarová A; Malis F; Josífko M
    Cesk Gastroenterol Vyz; 1978 Mar; 32(2):98-104. PubMed ID: 350435
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbenoxolone sodium: its role in ulcer healing.
    Langman MJ
    Drugs; 1976; 11(4):241-4. PubMed ID: 947739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term therapy with carbenoxolone in the prevention of recurrence of gastric ulcer. Natural history and evolution of important side-effects and measures to avoid them.
    Ganguli PC; Mohamed SD
    Scand J Gastroenterol Suppl; 1980; 65():63-71. PubMed ID: 6937941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind study of carbenoxolone in gastric ulcer and erosions.
    Lehtola J; Karvonen AL; Tunturi-Hihnala H
    Ann Clin Res; 1978 Feb; 10(1):19-23. PubMed ID: 354471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pirenzepine and carbenoxolone in the treatment of chronic gastric ulcer. A double-blind endoscopic trial.
    Bianchi Porro G; Petrillo M; Lazzaroni M; Mazzacca G; Sabbatini F; Piai G; Dobrilla G; De Pretis G; Daniotti S
    Hepatogastroenterology; 1985 Dec; 32(6):293-5. PubMed ID: 3912314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind trial of carbenoxolone and geranyl farnesyl acetate in gastric ulcer.
    Smith PM; Sladen GE; Beck ER; Bennett PN; Lennard JE; Langman JS
    Scand J Gastroenterol; 1975; 10(7):753-5. PubMed ID: 1103273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duodenal ulcer treated by carbenoxolone sodium. Endoscopically controlled trial (author's transl)].
    Carrilho FJ; Onishi I; Soares EC; Zeitune JM; Pareja JC; Amorim Filho J
    Arq Gastroenterol; 1978; 15(4):167-74. PubMed ID: 749854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric epithelial cell turnover, mucus production, and healing of gastric ulcers with carbenoxolone.
    Domschke W; Domschke S; Hagel J; Demling L; Croft DN
    Gut; 1977 Oct; 18(10):817-20. PubMed ID: 590840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.